Before founding Ciscovery Bio, Dr. Joonyul Kim had managed Proximity Biosciences as the founder CEO for 5 yrs. While at the company, he received multiple federal/state fundings including NSF STTR Phase I, and made research contracts with drug discovery companies.
Genomic Profiling Showcase:
Ciscovery Bio is a non-coding biomarker company that discovers and utilizes cis-regulatory modules for drug development and treatment.
Cis-regulatory Modules as Non-coding Biomarkers
Cis-regulatory modules (CRMs) are highly sensitive sensors for drug-induced cellular changes and strong candidates for precision medicine, but most of them still remain unexplored. Our genome-scale CRM discovery tool enabled more than 100,000 functionally-validated CRMs for profiling drugs and for searching the variants.
The PMWC 2022 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.